227 related articles for article (PubMed ID: 6453155)
1. In vitro induction of tumoricidal and suppressor macrophages by lymphokines: possible feedback regulation.
Taramelli D; Holden HT; Varesio L
J Immunol; 1981 Jun; 126(6):2123-8. PubMed ID: 6453155
[TBL] [Abstract][Full Text] [Related]
2. Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.
Taramelli D; Varesio L
J Immunol; 1981 Jul; 127(1):58-63. PubMed ID: 6787132
[TBL] [Abstract][Full Text] [Related]
3. Macrophage activation by interferon: dissociation between tumoricidal capacity and suppressive activity.
Boraschi D; Soldateschi D; Tagliabue A
Eur J Immunol; 1982 Apr; 12(4):320-6. PubMed ID: 6178603
[TBL] [Abstract][Full Text] [Related]
4. Relationship between murine macrophage Fc receptor-mediated phagocytic function and competency for activation for non-specific tumor cytotoxicity.
Leu RW; Rummage JA; Rahimi MB; Herriott MJ
Immunobiology; 1986 Apr; 171(3):220-33. PubMed ID: 3519439
[TBL] [Abstract][Full Text] [Related]
5. Dissociation between macrophage tumoricidal capacity and suppressive activity: analysis with macrophage-defective mouse strains.
Boraschi D; Pasqualetto E; Ghezzi P; Salmona M; Bartalini M; Barbarulli G; Censini S; Soldateschi D; Tagliabue A
J Immunol; 1983 Oct; 131(4):1707-13. PubMed ID: 6311895
[TBL] [Abstract][Full Text] [Related]
6. IFN-beta-induced reduction of superoxide anion generation by macrophages.
Boraschi D; Ghezzi P; Salmona M; Tagliabue A
Immunology; 1982 Apr; 45(4):621-8. PubMed ID: 6175565
[TBL] [Abstract][Full Text] [Related]
7. Requirement for protein synthesis for induction of macrophage tumoricidal activity by IFN-alpha and IFN-beta but not by IFN-gamma.
Blasi E; Herberman RB; Varesio L
J Immunol; 1984 Jun; 132(6):3226-8. PubMed ID: 6725951
[TBL] [Abstract][Full Text] [Related]
8. Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines.
Boraschi D; Tagliabue A
Eur J Immunol; 1981 Feb; 11(2):110-4. PubMed ID: 6163639
[TBL] [Abstract][Full Text] [Related]
9. Cellular origins and target cells of immunoregulatory factors in mice with disseminated histoplasmosis.
Deepe GS; Watson SR; Bullock WE
J Immunol; 1984 Apr; 132(4):2064-71. PubMed ID: 6230399
[TBL] [Abstract][Full Text] [Related]
10. Alteration of macrophage cytotoxicity through endogenous interferon and tumor necrosis factor alpha induction by propanil.
Theus SA; Tabor DR; Gandy J; Barnett JB
Toxicol Appl Pharmacol; 1993 Jan; 118(1):46-52. PubMed ID: 7679225
[TBL] [Abstract][Full Text] [Related]
11. In vivo activity of lymphokine-activated macrophages in host defense against neoplasia.
Fernandez-Cruz E; Ulich T; Schreiber RD
J Immunol; 1985 May; 134(5):3489-96. PubMed ID: 3920323
[TBL] [Abstract][Full Text] [Related]
12. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
[TBL] [Abstract][Full Text] [Related]
13. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures.
Ruco LP; Meltzer MS
J Immunol; 1977 Sep; 119(3):889-96. PubMed ID: 330759
[TBL] [Abstract][Full Text] [Related]
14. Role of bacterial lipopolysaccharide and lymphokine in the regulation of macrophage activation: correlates between secretion of plasminogen activator and tumor lysis.
Jones CM; Taramelli D; Clouse CA; Goldfarb RG
Immunobiology; 1984 May; 166(4-5):410-27. PubMed ID: 6541192
[TBL] [Abstract][Full Text] [Related]
15. Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities.
Kelso A; Glasebrook AL; Kanagawa O; Brunner KT
J Immunol; 1982 Aug; 129(2):550-6. PubMed ID: 7045227
[TBL] [Abstract][Full Text] [Related]
16. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.
Poste G; Kirsh R; Fogler WE; Fidler IJ
Cancer Res; 1979 Mar; 39(3):881-92. PubMed ID: 427777
[TBL] [Abstract][Full Text] [Related]
17. Suppression of T-cell mediated lymphokine production but not cytotoxic activity by macrophages.
Varesio L; Eva A; Cavallo G; Herberman RB
Boll Ist Sieroter Milan; 1980 Mar; 59(1):12-6. PubMed ID: 6970038
[TBL] [Abstract][Full Text] [Related]
18. Interferon decreases production of hydrogen peroxide by macrophages: correlation with reduction of suppressive capacity and of anti-microbial activity.
Boraschi D; Ghezzi P; Pasqualetto E; Salmona M; Nencioni L; Soldateschi D; Villa L; Tagliabue A
Immunology; 1983 Nov; 50(3):359-68. PubMed ID: 6354920
[TBL] [Abstract][Full Text] [Related]
19. Effect of recombinant human tumor necrosis factor on the induction of murine macrophage tumoricidal activity.
Hori K; Ehrke MJ; Mace K; Maccubbin D; Doyle MJ; Otsuka Y; Mihich E
Cancer Res; 1987 Jun; 47(11):2793-8. PubMed ID: 2882835
[TBL] [Abstract][Full Text] [Related]
20. Similarities among factors that render macrophages tumoricidal in lymphokine and interferon preparations.
Schultz RM; Chirigos MA
Cancer Res; 1978 Apr; 38(4):1003-7. PubMed ID: 346202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
